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Design, synthesis and structure of an amphipathic peptide with
pH-inducible haemolytic activity
Rudolf Moser
Biochemisches Institut der Universitat Zurich, Winterthurerstrasse 190,
CH-8057 Zurich, Switzerland
A synthetic, 26-residue peptide having a strong helix forming
potential in the protonated state was designed to interact with
lipid bilayers in a pH-dependent way. On the basis of this
concept a cluster of four glutamic acid residues was inserted
in the central region of the amphipathic peptide to promote
helix destabilization by mutual charge repulsion at neutral
pH. Protonation of these residues might then bring about both
a pH-mediated change in hydrophobicity and conformation
forming a membrane-active amphiphilic helix. The sequence
GLGTLLTLLEFLLEELLEFLKRKRQQamide produced by
the design strategy induced pH-triggered lysis of human
erythrocytes. A molecular model correlating the lytic activity
to the formation of transmembrane pores which were detected
by electron microscopy in erythrocyte membranes is
discussed. Circular dichroism studies indicated a self-
association of the monomeric random coil form with
increasing peptide concentration leading to the apparent
induction of strong a-helix formation (~ 100% helicity) in the
fully aggregated state. However, no pH-dependent helix-
random coil transition was observed, implying that
interhelical hydrophobic and ionic interactions not only
govern the self-association but also decisively influence the
conformational stability of the peptide.
Key words: amphipathic helix/CD studies/molecular modelling/
pH-dependent haemolytic activity/transmembrane pores
Introduction
One of the key problems in molecular biology is to understand
the question of how the primary amino acid sequence of a protein
determines its specific three-dimensional structure and the
pathway of folding. One approach to this problem involves the
construction of model peptides designed to form a desired
conformation (DeGrado, 1988). Peptides shorter than ~30
residues are, in general, predicted not to show marked
conformational preferences, remaining unfolded and, rather than
forming the medium and long-range interactions (typically
hydrogen and ionic bonds and van der Waals interactions) that
stabilize native protein structures, form preferential interactions
with the solvent water. The presence of a well-defined structure
in such peptides in aqueous solution is therefore unusual, although
in contrast, organic solvents are known frequently to induce
relatively stable conformations. The lack of stability of isolated
secondary structure elements (especially intramolecular H-bonded
a-helices) is sometimes considered as evidence against their
participation as nucleation centres, forming individual folding
units, in the initiation of the protein folding process.
Designing an a-helical peptide is greatly facilitated by the
existence of considerable, detailed information about factors that
stabilize this conformation in aqueous solution (De Grado et al.,
1989). Research is currently being directed towards establishing
factors which influence the stabilization of secondary structure
units, especially a-helices in short peptides. Recent studies on
synthetic a-helical peptides have shown that a-helix stability is
strongly influenced by the distribution of charged side chains
which interact with the helix dipole and which can also form salt
bridges (Baldwin and Eisenberg, 1987; Marqusee and Baldwin,
1987). In addition, hydrophobic side-chain interactions are partly
responsible for the unexpectedly high helical content of short
peptides and are thought to play a key role in the protein (peptide)
folding process (Dill, 1990).
Relatively stable a-helical secondary structure units have been
reported for several peptides in purely aqueous media or mixtures
of water and organic solvents (the values in brackets being the
number of residues in the peptide): (13) peptide analogues of
C-peptide of ribonuclease A (Merutka and Stellwagen, 1989);
(25) peptide fragments of bovine growth hormone (Brems et al.,
1987); (37) antifreeze polypeptide from the winter flounder (Yang
et al., 1988); (17) DNA binding helix F of cAMP receptor
protein of Escherichia coli (Clore etal, 1985); (16/74) four-
helix bundle proteins (Ho and DeGrado, 1987; Regan and
DeGrado, 1988); (79) four-helix bundle protein 'Felix' (Hecht
et al., 1990); (30) pH-dependent, amphiphilic a-helical peptide
(Subbarao et al., 1987); (21) membrane-spanning, amphiphilic
a-helical peptides (Lear et al., 1988); (16/17) alanine-based, salt
bridge-stabilized, a-helical peptides (Marqusee and Baldwin,
1987); (28) a-helical peptide fragment of the N-terminus of
human pituitary growth hormone (Roongta et al., 1989); (43)
peptides corresponding to the isolated leucine zipper regions from
Fos and Jun nuclear proteins (O'Shea etal., 1989); (17)
monomeric, a-helical peptides containing 19 different central-
residue replacements (Merutka etal., 1990); (17) peptide
analogues (Padmanabhan et al., 1990) of an (16) alanine-based,
monomeric, a-helical peptide (Marqusee et al., 1989); (17) cation
stabilized a-helices (Ghadiri and Choi, 1990). The stability of
the a-helix formed by many of the peptides mentioned above
is much higher than would be predicted from the Zimm and Bragg
theory (Zimm and Bragg, 1959). However, the stability of these
a-helices should be considered in terms of a dynamic model,
where molecules change rapidly between many different con-
formations including unfolded states but exhibit, to a greater or
lesser extent, strong preferences to adopt a low energy a-helical
state, rather than a static rigid structure (Wright et al., 1988;
Bradley et al., 1990).
In the present study I have examined whether it is possible
to design a polypeptide which increases in hydrophobicity as the
pH decreases from neutral to acidic and thereby folds into an
amphiphilic a-helix. Such surface-active helices are known to
promote strong protein/peptide-membrane interactions and are
commonly found in membrane-associated proteins and
membrane-active peptides. Thus, the peptide would be expected
to induce pH-triggered haemolysis of human erythrocytes, and
therefore I have adopted the name Helical Erythrocyte Lysing
Peptide (HELP) for this substance.
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Materials and methods
Design and structure-function relationship
In designing a putative, amphiphilic a-helix, the following factors
have to be taken into account: (a) the helical propensity and the
hydropathy of the amino acid residues used; (b) the length of
the peptide; (c) the charge distribution on the a-helix surface;
(d) the establishment of the amphiphilic character and (e) the
solubility of the peptide in water. Although the contribution of
single factors to the helix stability is partly understood, the
strategy of using a well-characterized peptide as a structural
template might be more successful than a de novo design ap-
proach.
The three-dimensional structure of bee venom melittin from
Apis mellifera (BVM), a small peptide toxin containing 26 amino
acid residues (Eisenberg, 1984), has been determined by X-ray
analysis (Terwilliger and Eisenberg, 1982) and by 'H 2D NMR
spectroscopy (Bazzo etai, 1988; Ikura etai, 1991) and
therefore, was taken as the main starting point for the construction
of the 26-residue amphiphilic HELP helix. BVM and its
analogues have been studied extensively under different condi-
tions (Blondelle and Houghten, 1991) and it undergoes a pH,
salt and peptide concentration dependent random coil/helix transi-
tion upon tetramerization (Bello et al., 1982; Quay and Condie,
1983). Several models exist to explain the spontaneous interac-
tion of BVM with lipid bilayers upon which it acts as an effec-
tive lytic agent (Vogel and Jahnig, 1986; Dawson et al., 1978).
Additional sequence and structure information for the design of
HELP was obtained from studies on a synthetic model toxin
(DeGrado et al., 1981) and on 5-haemolysin from Staphylococcus
aureus (Tappin et al., 1988; Raghunathan et al., 1990;
Thiaudiere etai., 1991).
The amino acid sequence of HELP was chosen by examining
the three-dimensional structure of BVM and replacing most of
the residues of the hydrophobic helical face by Leu (which is
not only hydrophobic but also has a high a-helical potential) and
some of the hydrophilic residues by Glu and Thr in such a way
that the central region of the putative a-helix was composed
purely of residues with high helix-forming propensities (Chou
and Fasman, 1974; Argos and Palau, 1982; Palau et al., 1982).
Residues with a high turn potential are often found at the N-
terminus of a-helices (Richardson and Richardson, 1988) and
therefore Thr was included in the initial turn of the helix as it
has the added advantage of potentially H-bonding back onto the
amide backbone and thereby aiding helix initiation (Palau et al.,
1982). Strongly polar residues (mainly glutamic acid) were used
when the design of the helix dictated the incorporation of a
hydrophilic residue (i.e. for those residues forming the
hydrophilic face of the helix) in order to ensure that the peptide
would be soluble in water. The structure of HELP was completed
by adding a short helix inducing sequence at the N-terminus and
the basic C-terminal hexapeptide portion of BVM was added to
the C-terminus since it is known that this hexapeptide is essential
for the lytic activity of BVM. The C-terminal a-carboxyl group
was blocked by an amide group whereas the N-terminal a-amino
group remained unprotected. Thus, helix destabilization could
occur at the N-terminus by unfavourable interactions of the
positively charged amino group with the helix dipole. The
negative pole of the a-helix dipole is localized near the
C-terminus, and therefore the positively charged Lys and Arg
residues close to the C-terminus would be expected to favour
structure stabilization and to mitigate against aggregation.
However, short peptides, including BVM, often show
aggregation-induced structure formation because of their tendency
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to be amphipathic. Such aggregated states or supersecondary
structures (e.g. four a-helix bundles) arise from the alignment
of and interaction between the hydrophobic residues of monomer
units (Chothia et al., 1977; Chothia, 1984; Regan and DeGrado,
1988; Cohen and Parry, 1990).
Were a helix to form at neutral pH, the glutamate residues
occupying the central part of the hydrophilic helical face would
be expected to exhibit mutual charge repulsion and thereby
destabilize the helix. Protonation of these residues (by lowering
the pH) might then bring about a coil/helix transition, forming
a membrane-active helix with both hydrophilic and hydrophobic
faces. The folding of the primary sequence into a putative a-helix
was simulated using computer-generated graphics; and energy
minimization techniques were employed to optimize the design
stepwise, leading to the final HELP sequence and to examine
if a stable structure could indeed be adopted.
Computer modelling
The structural aspects of the putative a-helix were examined by
the macromolecular computer modelling system INSIGHT and
DISCOVER from Biosym Technologies. These programs were
used to simulate a molecular model of HELP. The amino acid
side chains were attached onto the a-carbon backbone of an
idealized, right-handed a-helix with uniformly constant phi and
psi angles ($ = -57° , i/< = -47°) and 3.6 residues per helix
turn. The a-helix was soaked with water molecules and the
potential energy of the structure was minimized using a conjugate
gradient minimization on a force field equation which is
dependent on the positions of the atoms of the molecule.
Molecular mechanics for energy minimization calculations were
performed on a Micro Vax II (Digital Equipment Corporation)
and for structure visualization of the minimal energy conformation
displayed on an Evans and Sutherland PS390 system.
Synthesis and purification
The peptide was synthesized as a C-terminal amide on a/?-methyl-
benzhydrylamine (poly sty rene/1% divinylbenzene) resin
(150-200 mesh) by the solid-phase method of Merrifield as
described by Stewart and Young (1984) using dichloromethane
(DCM) as the solvent, 40% (v/v) trifluoroacetic acid
(TFA)/DCM for deprotection and 10% (v/v) triethylamine/DCM
for neutralization. Residual amino groups on the resin (Boc-Gln-
resin loading: 0.30 mmol/g resin) were blocked by the addition
of acetic anhydride. The peptide was synthesized using DCC-
activated derivatives (4.2-fold molar excess) of Boc-Arg (N6-
Tos), Boc-Glu (O^-Bzl), Boc-Gly, Boc-Leu, Boc-Lys
(/V-2-CIZ), Boc-Phe, Boc-Thr (OBzl). For Boc-Gln, the
HOBt/DCC coupling method was used (Konig and Geiger, 1970).
The coupling reactions were performed twice for all residues.
The standard HF method (scavenger: anisole) was used for side
chain deprotection and cleavage of the peptide from the support.
The peptide was extracted from the resin with 1 M acetic acid
(HOAc) and lyophilized.
HELP was purified in a three step procedure by (a) gel filtration
on Bio-Gel P-6 (200-400 mesh, 1000 x 20 mm) in 0.1 M
HOAc, (b) preparative HPLC on a size exclusion column (Ultra
Pac TSK-G 3000 SWG, TP 5000, 600 X 21.5 mm, LKB) in
0.2 M HOAc and (c) by semipreparative reverse-phase HPLC
(Aquapore RP-300, C-8, 7 /tm, 250 X 7 mm, Brownlee Labs)
equipped with a precolumn (Aquapore RP-8, 7 /xm,
15 x 3.2 mm), solvent system A: 0.1% (v/v) TFA in water,
B: 0.08% (v/v) TFA in water : acetonitrile 20:80 (v/v) using
a linear gradient from 60% B in A to 70% B in A generated
in 45 min.
Characterization of a designed haemolytic peptide
The homogeneity of the synthetic peptide was confirmed by
(a) analytical reverse-phase HPLC (Nucleosil NS-300, C-8,
5 /*m, 250 X 4.0 mm, Macherey and Nagel), solvent systems
A and B as above, (b) capillary electrophoresis, (c) complete
amino acid sequence analysis, (d) amino acid analysis after
peptide hydrolysis in 5.7 N HC1, 5% thioglycolic acid at 110°C
for 48 h under vacuum [composition: Thr, 1.80 (2); Glx, 5.99
(6); Gly, 2.01 (2); Leu, 10.04 (10); Phe, 2.02 (2); Lys, 1.97
(2); Arg, 2.13 (2)] and (e) FAB mass spectral analysis
[(M + H)+ peak at 3099.8, calculated = 3099.8].
Circular dichroism
Unless indicated otherwise, circular dichroism (CD)
measurements were always performed at 22 °C on a Jasco model
J-500C spectropolarimeter equipped with an Epson (model
QX-10) computer for data processing using 10.0, 1.0, 0.2 and
0.1 mm pathlength cuvettes. The results were reported as mean
residue ellipticity ([0]), in deg cm2/dmol. Peptide concentra-
tions were determined by amino acid analysis. Samples contain-
ing guanidine hydrochloride (GuHCl) or urea used for
denaturation studies were incubated overnight at room
temperature before recording the spectra. Full-range, solvent
subtracted CD spectra were recorded for all experiments over
the wavelength range 300—185 nm in order to detect any changes
in the spectral features associated with the a-helicity.
For a rough evaluation of the a-helical content of HELP from
CD spectra the following formulae were used: (a) % a-helix =
{(-[91208 - 4000)/29 000! * 100% (Greenfield and Fasman,
1969), (b) % a-helix = | ( - [ e ] 2 2 2 - 2340)/30 300) X 100%
(Chen etal., 1972). The CD spectra were further analyzed
between 190 nm and 240 nm using the method of Provencher
and Glockner (1981) for the estimation of protein secondary
structures based on CD spectra.
Haemolysis assay
Fresh human blood used for haemolysis experiments was obtained
by venipuncture and coagulation was inhibited by the addition
of sodium citrate. The blood was stored at 4°C for a maximum
of two days. Following centrifugation, 2 ml packed human red
blood cells (hRBC) were washed three times in 20 mM sodium
acetate (NaOAc), pH 5.0 or 20 mM Tris(hydroxymethyl)
amino-methane (Tris)-HCl pH 7.5 both containing 116 mM
NaCl and recentrifuged. Packed cells were then resuspended in
100 ml of the same buffers. Morphological studies using elec-
tron microscopy showed intact hRBC in the buffer at pH 7.5
and spherical, swollen, but unlysed cells at pH 5.0. For the lysis
experiments 2 ml of this hRBC solution was incubated with 2 ml
of buffer containing the test peptide for 30 min at 37 °C. After
centrifugation of the sample for 5 min in a microfuge the
absorbance of the supernatant was read at 578 nm.
Electron microscopy
hRBC were incubated with HELP in 20 mM NaOAc, 116 mM
NaCl, pH 5.0 for 30 min at 37°C as described in the previous
section. Cell membranes were recovered, resuspended in 1 ml
20 mM Tris-HCl, 116 mM NaCl, pH 7.5 and treated with
60 ng trypsin and chymotrypsin for 45 min at 37 °C to digest
outer membrane proteins in order to reduce background staining
while leaving the membrane structure intact (Bhakdi and Tranum-
Jensen, 1987). Membranes were then washed several times with
the same buffer, resuspended and placed on a carbon-coated
copper grid and negatively stained with 2% (w/v) sodium
phosphotungstate, pH 6.5, for electron microscopy. The
specimens were examined with a transmission electron
microscope (model TEM 420, Philips). Pores were detected
whereas, in control experiments at pH 7.5, no pores could be
seen in proteolytically digested membranes of HELP-treated
hRBC in 20 mM Tris-HCl, 116 mM NaCl, disrupted with a
sonifier (model B-15, Branson).
Results
Design
A sequential comparison between HELP and three other lyrically
active peptides is illustrated in Figure 1. The distribution of the
hydrophobic and hydrophilic amino acid residues in the putative
helix are demonstrated in the helical-wheel plot and the helical
net diagram (see Figure 2). The mean helical hydrophobic mo-
ment (< / i> ) and the mean hydrophobicity ( < H > ) of HELP
(residues 12-22), which were calculated according to Eisenberg
etal. (1984) using the normalized consensus hydrophobicity
scale, were 0.736 and 0.022, respectively. The values obtained
are typical for a 'surface-seeking' amphiphilic a-helix in peptides
which promote cell lysis (Eisenberg etal., 1984). However,
HELP did not have an amphiphilic a-helical structure in the strict
sense because there are non-hydrophilic residues (Fll) on the
hydrophilic side of the helix and vice versa (K23, R24) (see
Figures 2 and 3). As a consequence, the values for </*> and
< H > of the entire HELP helix (residues 1-26) were rather
small, 0.348 and 0.043, respectively.
Secondary structure prediction methods in combination with
computer modelling techniques have been used to investigate the
conformation^ constraints. A molecular model of HELP
simulated by computer graphics and energy minimization
techniques indicated that well-defined a-helical conformations
could be obtained. The structure of the putative helix generated
by these studies (see computer modelling) is displayed in Figure
3. At neutral pH residues Glyl (a-NH3+); GlulO, 14, 15, 18;
Lys21, 23 and Arg22, 24 are in the ionized state. The analysis
of the distribution of oppositely charged residues in the molecular
model shows that at pH 7 only Glu"18/Lys+21 (i/i + 3) or
Glu~18/Arg+22 (i/i + 4) are properly positioned to form an
intrahelical salt bridge and could therefore contribute additional
stability to the structure, whereas at acidic or basic pH, helix
stabilization through singly charged H bonds between
Glu°18/Lys+21 or Glu°18/Arg+22 and between GhT18/Lys°21
or Glu"18/Arg°22 respectively could occur. In an environment
of low dielectric constant such as methanol (MeOH) or the
hydrophobic interior of a membrane these electrostatic inter-
actions between ionic residues even are enhanced.
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Fig. 1. Sequential comparison between the lytic active peptides HELP (A),
BVM from Apis mellifera (B), (Eisenberg, 1984), synthetic model toxin
(C), (DeGrado el ai, 1981) and 5-haemolysin from Staphylococcus aureus
(D), (Tappin et ai, 1988). Boxed amino acid residues in corresponding
sequence positions are either identical or have similar properties.
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Fig. 2. (a) axial projection of the a-helical structure of HELP with the N-terminus to C-terminus orientation arranged from the top to the bottom. The
segregation of the hydrophilic and hydrophobic residues, printed in bold, is shown in the helical wheel diagram. The N-terminal residue Gly I is placed at
position number one and the second position on the helical wheel, which is occupied by Leu 2 is located at an angle displaced by 100° from position number
one and so on. (b) Surface net representation of the a-helical structure of HELP. The helical cylinder was split lengthwise along the hydrophilic face opposite
the hydrophobic Leu area and the distribution of nonpolar residues, printed in bold, is illustrated.
Fig. 3. The wire frame structure of the minimal energy conformation of the putative a-helix obtained by molecular modelling studies of the conformation of
HELP at acidic pH (ionization state of the molecule, Gly + 1 (a-NH3+); Glu°10, 14, 15, 18; Lys+21, 23 and Arg+22, 24) is displayed in a stereoview. For
the sake of clarity H atoms are omitted in the representation.
However, the modelling studies also supported the pH-induced
helix/coil transition model produced by the design strategy (see
design and structure-function relationship) with a strong helix
perturbation effect at pH 7 induced by charge repulsion of the
central, ionized Glu residues: Glu~10/Glu~14 (i/i + 4),
Glu"14/Glu"18 (i/i + 4) and Glu~15/GhT18 (i/i + 3).
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Circular dichroism
Helix formation in HELP was studied under various conditions,
and the CD spectra recorded were of qualitatively similar shape
differing only in the absolute values of [9] . In the pH-range
2.0-12.0 HELP was soluble at high concentration in aqueous
buffers. In the presence of 100 mM NaCl a sharp decrease in
Characterization of a designed haemolytic peptide
260
200 220 240
Wavelength (nm)
260
Fig. 4. (a) The far-UV CD spectra represent a theoretical spectrum derived
from the CONTIN program (Provencher and Glockner, 1981) for a protein
of 100% a-helix content ( • ) overlaid on the measured HELP spectrum
(—) of the peptide (275 ^M) dissolved in 10 mM NaOAc, pH 4.2 (b) CD
spectra of HELP dissolved in MeOH adjusted to 'pH' 3 0 (—), 5.0 (—)
and 8.0 ( ).
the solubility was observed above pH 4.5. The CD spectral
features and the absolute mean residue ellipticities were not
significantly affected by the addition of 100 mM NaCl to HELP
dissolved in buffers at different pH values. In addition, in the
'pH'-range 3.0-8.0 HELP was soluble in methanolic solution
(MeOH adjusted to the desired pH with either 2 N aqueous HC1
or NaOH). In aqueous buffers, the helicity as derived from the
ellipticity [9] at 222 nm was concentration dependent (see Figure
5) and an aggregation induced increase of the estimated a-helix
content with increasing peptide concentration could be detected
The increase in the helicity reached a plateau at ~ 50 /tM peptide
with [9]222 = ~29 300 deg cm2/dmol. In the presence of
7.2 M GuHCl or 8.1 M urea, the concentration-dependence of
the curve is shifted towards a higher peptide concentration
indicating a decreased stability of the folded, aggregated form
of HELP (see Figure 5). Thus, in the self-associated a-helical
state, HELP exhibited considerable stability to high concentrations
of chaotropic denaturants whereas at low peptide concentration
the structure appears to be more susceptible to denaturation and
it was under these conditions that HELP was found to exist in
a predominantly random coil conformation.
The influence of charge effects on a-helix formation was
evaluated by measuring CD spectra of the fully aggregated form
of HELP as a function of side-chain ionization. The pH-
dependence of helix formation, as estimated by [9]222> >s
displayed in Figure 6a. In aqueous buffers in the basic pH range
the helicity increased slightly, indicating that this effect arose from
titration of the €-amino group of lysine, whereas in methanolic
solution HELP seemed to be most stable at acidic pH (see Figure
4b). It is interesting to note that HELP showed no significant,
pH-triggered conformational changes (random coil/a-helix
transition) as the CD spectra remained almost unaffected at
different pH values.
The helical structure of HELP at acidic pH should be destabilized
if the temperature is increased and, to investigate this, CD spectra
were recorded as a function of temperature between 5.5 and
©
50 100 150
[peptide] |iM
Fig. 5. Peptide concentration dependence of the mean residue ellipticity
[G]222- CD spectral measurements were made at 22°C on HELP dissolved
in 10 mM NaOAc, pH 4.2 ( • ) , 10 mM NaOAc, 8.1 M urea, pH 4.2 ( • ) ,
and 10 mM NaOAc, 7.2 M GuHCl, pH 4.2 (A).
1 3 5 7 9 11 13 0 10 20 30 40 50 60 70
pH Volume %TFE
Fig. 6. (a) pH dependence of the mean residue ellipticity [0)222 f°r HELP
(200 fiM). (b) TFE concentration dependence of the mean residue ellipticity
[O]222- CD spectral measurements were made on HELP (80 pM) dissolved
in 10 mM NaOAc buffer, pH 4.2 with increasing TFE concentration.
95 °C. The helical content of HELP was linearly dependent on
temperature as estimated from [9]208 an<J [9]222 values (see
Figure 7) and showed maximal helicity at low temperatures, while
increasing the temperature gradually unfolded the helical
structure, although a complete conformational transition was
never observed. The thermal unfolding transition was broad and
fully reversible, neither reaching 100% helix formation at low
temperatures nor 100% random coil formation at high
temperatures. As the temperature was increased the CD spectra
showed an isodichroic point at 201 nm, which might indicate the
existence of a transition between only two conformational forms,
a-helix and random coil.
The characteristic CD spectrum of HELP is displayed in Figure
4. The spectrum in the 190-240 nm region with a maximum
at 193 nm and local double minima at 208 nm and 222 nm is
typical for all-a-helical peptides (Greenfield and Fasman, 1969)
and is highly suggestive of the presence of a,unique folded, helical
structure. To study the conformation of the peptide in a
hydrophobic environment, CD spectral measurements were made
on HELP dissolved in MeOH and in aqueous buffers containing
increasing concentrations of 2,2,2-trifluoroethanol (TFE), which
is known to enhance intramolecular interactions and therefore
has been used as an a-helical structure-inducing and stabilizing
solvent (Nelson and Kallenbach, 1986). In methanolic solution
neither pH-triggered a-helix/coil transition (see Figure 4b) nor
concentration dependent changes in the helicity were observed
in the peptide concentration range of 1 —500 pM at acidic pH,
indicating that HELP formed no aggregates under these
conditions. Addition of TFE to HELP dissolved in 10 mM
327
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Fig. 7. Variation of the mean residue elhpticity [O]2o8 ( d ) a n^ [Q]222 (M)
as a function of temperature. CD spectral measurements were made on
HELP (620 fiM) dissolved in 10 mM NaOAc, pH 4.2.
NaOAc buffer, pH 4.2 resulted in a further increase in the
a-helical content which reached a plateau at - 4 0 % TFE with
[e]2 2 2 = - 3 6 100 deg cm2/dmol (see Figure 6b).
A rough evaluation of the secondary structure content of HELP
gave 100% a-helix [formula (a), (Greenfield and Fasman, 1969)]
and 89% a-helix [formula (b), (Chen etal, 1972)],
respectively.The CONTIN program of Provencher and Glockner
has been thought to give the most accurate results of the common
methods used for secondary structure calculation of peptides from
CD spectra. Under aqueous solution conditions (10 mM NaOAc,
pH 4.2, 22°C) and in the fully aggregated state (> - 5 0 /*M,
see Figure 5) HELP was calculated to be - 100% helical. The
computer-simulated fit of the CD spectrum for a peptide
containing 100% a-helix is in excellent agreement with the
spectrum of HELP as illustrated in Figure 4a. However, several
factors influence and complicate the estimation of the helical
content in short peptides, including end effects produced by
residues not H-bonded to the backbone at the distorted N- and
C-termini of the a-helix, the contribution of aromatic amino acid
residues and the lack of absolute reference spectra of a peptide
in a complete helical or random coil state. In addition, CD signals
for a-helices are known to be chain length dependent (Chen et al.,
1974) and therefore the calculated values should be taken only
as an approximation of the a-helix content of HELP.
Haemolysis
The lytic activity of HELP on biological membranes can be
conveniently monitored by the release of haemoglobin from
hRBC. The percentage haemolysis was related to that of a
completely lysed reference sample. In the assay no spontaneous
haemolysis was observed in the absence of peptide. Comparative
experiments were all performed on the same hRBC suspensions
and BVM was always included as a positive control. At acidic
pH, haemoglobin release by HELP appeared to follow kinetics
comparable to those measured for BVM at neutral pH. In
addition, the dose response curves for the extent of leakage are
almost identical (see Figure 8). It was shown by titration
experiments that, during the membrane disruption process, HELP
was not released to act in a second lytic cycle and, once
membrane associated or integrated, it was unable to lyse further
cells. For HELP, BVM and a fragment of HELP (residues 9-26)
a series of haemolysis assays were performed over a peptide
concentration range of 0—50 /tM. Since HELP and BVM reached
the same plateau value of 100% lytic activity at peptide
0.4
[peptide]
Fig. 8. The haemolytic activity of HELP compared with that of BVM using
hRBC as target. Lysis is expressed in z units by using the Poisson analysis
(z = -In [1 - y], where y is the fraction of lysed cells as determined by
the haemoglobin release in the haemolytic assay at 37°C for HELP ( • ) ,
BVM ( • ) and HELP fragment (A) at pH 5.0 and for HELP ( • ) , BVM
(O) and HELP fragment (A) at pH 7.5. The inset shows the HELP-
induced leakage of hRBC at different pH values. Lysis measurements were
made on HELP dissolved in the following buffers each containing 116 mM
NaCl: 20 mM NaOAc, pH 4.8; pH 5.0; pH 5.5, 20 mM potassium
phosphate, pH 6.0; pH 6.5; pH 7.0 and 20 mM Tris-HCI, pH 7.5; pH
8.0.
Fig. 9. Electron micrograph (magnification factor: 294 000) of pores in
membrane preparations of HELP-lysed hRBC. For details see electron
microscopy section.
concentrations higher than — 1 /iM, only the concentration-
dependent range of 0 - 1 /tM is displayed in Figure 8. Peptide-
induced leakage of haemoglobin from hRBC was pH-dependent.
The extent of leakage as a function of pH with a constant
HELP/hRBC ratio was recorded (see Figure 8 inset). At pH 5.0
the lytic activity was maximal and dropped to zero as the pH
increased. Incubation of hRBC and HELP at pH 7.5 did not lead
to the release of haemoglobin from erythrocytes. In membrane
preparations of HELP-lysed hRBC, round pores with an outer
diameter of 8.3-10 nm and an inner diameter of 2.3-2.9 nm
were detected by transmission electron microscopy (see Figure 9).
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Discussion
Design and structure of HELP
A 26 residue peptide that induces pH-triggered haemolysis in
hRBC at pH 5.0 has been designed, synthesized and characterized
by several methods. Secondary structure prediction analysis
(Argos et al., 1976, 1982) and computer modelling (see Figure
3) suggest that HELP would have a high a-helical structure
content. Indeed, all results so far from CD measurements are
consistent with the assumed secondary structure model. CD
studies and analytical ultracentrifuge experiments (results not
shown) performed to establish the aggregation state of the
molecule strongly support the assumption that HELP forms a
self-aggregation-induced, highly a-helical structure in purely
aqueous solution at sufficiently high peptide concentrations
(> ~ 50 /tM) whereas, at lower concentrations the CD spectra
indicate a considerably lower helical content (see Figure 5).
Therefore, it appears to be reasonable to assume a dynamic
model, with an interconversion process between the monomeric
random coil and the aggregated a-helical state, where the HELP
molecule most probably populates multiple low energy conforma-
tions rather than occupying a single rigid structure, but preferen-
tially adopts a well-defined a-helical conformation upon
association. A possible explanation for the driving force of self-
association, is that Leu residues with a high helical potential are
tightly packed in an amphiphilic a-helix and are thus optimally
shielded from the polar environment in the aqueous phase by
aggregation along the hydrophobic faces. These strong inter-
molecular attractive interactions between hydrophobic regions
complemented by interhelical salt bridges (ion pairs) may also
suppress the unfolding tendency of the helix at neutral pH and
thus, might offer a rationale for the fact that HELP exhibits no
pH-dependent random coil/helix transition. It is interesting to note
that, despite the presence of only one intrahelical pair of amino
acid residues positioned to form salt bridges (Glu~18/Lys+21
or Glu"18/Arg+22) or singly charged H bonds (Glu°18/Lys+21
or Glu°18/Arg+22) at pH 4.2 (Marqusee and Baldwin, 1987),
HELP demonstrates a considerable stability towards both
chemical and thermal denaturation (see Figures 5 and 7). These
observations underline the importance of strong HELP-HELP
interactions which not only govern the monomer-aggregate
equilibrium but also effectively stabilize the helical conformation
even under strongly chaotropic conditions.
CD spectroscopy is a very sensitive tool with which to trace
structural changes. As shown by CD measurements the helicity
can be further increased by the addition of TFE (see Figure 6b).
Although these findings are indicative of additional structure
induction (e.g. in unordered regions at the N-, C-termini), helix
stabilizing effects (enhanced H-bonding geometry) or an increased
helix population (random coil-helix interconversion) cannot be
ruled out.
The fact that the peptide concentration in MeOH did not affect
the CD spectra strongly indicates that under these conditions
HELP remained monomeric while maintaining a stable a-helical
conformation. This assumption was further confirmed by NMR
studies on the aggregation state of HELP in MeOH. Since the
CD spectra of HELP dissolved in MeOH and in aqueous buffers
are quite similar (see Figure 4) it is reasonable to assume that
the molecular geometry of HELP is essentially the same in both
solvents. The CD results, which reveal a unique folded a-helix,
have been fully confirmed by the detailed investigations of the
solution conformational properties of HELP using high-resolution
'H 2D NMR-spectroscopy and molecular dynamic simulations
(Klaus and Moser, 1992). These findings suggest that the hydro-
carbon portion of MeOH could replace the interhelical
hydrophobic contacts in aggregates and therefore the solution con-
formation of HELP in MeOH, which might to some degree
mimic the hydrophobic interior of a membrane, could also repre-
sent a model for a single transmembrane HELP pore constituting
building block.
Structure-junction relationship and comparison with models
Amphiphilic a-helices are thought to represent the sites of
interaction between haemolytic peptides and lipid bilayers and
to be responsible for lytic function. Since haemolytic activity of
HELP and BVM can be continuously monitored on going from
peptide concentrations < 1 /iM to the concentration range of
1 - 5 0 fiM, where the activity curves of both peptides reach the
same plateau value (100% lysis), it becomes of interest to explain
how membrane disrupting activity could be related to the different
conformations which, as shown by the CD studies (see Figure
5), are present in the monomer-aggregate equilibrium. HELP
can be considered as a BVM analogue. Indeed, both peptides
adopt an a-helical conformation in the self-aggregated state in
water and exist as a monomeric a-helix in MeOH. However,
it should be noted that HELP has a stronger tendency to form
aggregates than BVM and therefore shows substantial helicity
([6]222 = —13 400 deg cm2/dmol) at a peptide concentration
of 1 nM (see Figure 5), whereas BVM at the same concentration
at pH 7.5 is expected to be in a predominantly monomeric random
coil state (Dawson et al., 1978; Brown etal, 1980).
Furthermore, CD and NMR studies indicate that in aqueous solu-
tion monomeric BVM preferentially exists in an unordered
conformation, whereas in the presence of membranes or in
MeOH, BVM monomers adopt an a-helical conformation similar
to that in the tetrameric state (Brown et al., 1980; Bazzo et al.,
1988). These findings, when considered together, support the
assumption that monomeric HELP and BVM reflect structural
similarities in that they probably form an amphiphilic a-helix
in the membrane-active conformation when bound to the polar
surface of the lipid bilayer. Thus, a preformed amphiphilic
conformation seems not necessarily to be a basic requirement
for lytic activity.
Since no membrane disrupting activity (transmembrane pore
formation) was observed at neutral pH, the formation of the
lytically active conformation seemed to be correlated to the
increased hydrophobicity upon protonation of the Glu side chains,
and gradual deprotonation of these side chains with increasing
pH might prevent HELP from penetrating into the apolar lipid
core. In this connection, it is interesting to note that BVM is
known to induce fusion of lipid vesicles at neutral as well as at
acidic pH values, whereas succinylated BVM cannot induce fu-
sion at neutral pH but initiates rapid and efficient fusion at acidic
pH, suggesting that the membrane fusion activity of succinylated
BVM is triggered by protonation of its carboxyl groups (Murata
etal, 1987). Thus, HELP and succinylated BVM are both
sensitive to pH-induced charge effects leading to altered func-
tional properties. It is known that truncated forms of BVM
(residues 7-26 and 8-26) are only slightly active whereas BVM
(residues 1 —20) is completely inactive but is capable of binding
to erythrocytes membranes (Schroder et al., 1971). A fragment
of HELP (residues 9—26) was also studied in order to deter-
mine the influence of chain length on the hRBC disruption
process. This shortened HELP version, lacking the helix-inducing
N-terminal sequence, showed a drastically decreased haemolytic
potency at pH 5.0 (see Figure 8).
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At present it is difficult to provide more than a phenomeno-
logical description of the haemolytic activity of HELP, since
peptide induced damage to cell membranes by both pore-
forming and other leakage-inducing mechanisms are complex and
remain to be established in detail (Bhakdi and Tranum-Jensen,
1987) even in the case of BVM, whose membrane-disrupting
effects have been studied extensively. A possible model for an
initial peptide^lipid complex and for peptide-induced membrane
destabilization (disordering and reorientation of lipid molecules)
could be described as follows: (1) the basic N-terminal hexa-
peptide portion of the peptide anchors HELP to the hRBC surface
through salt bridges between positively charged side chains
(Lys+ and Arg+) and the phosphate groups of the phospholipids
in the hRBC membrane; (2) extensive structural rearrangements
upon spontaneous incorporation of HELP into the lipid bilayer
occur; (3) polar membrane-spanning pores are formed by HELP
clusters, exposing the hydrophobic face of the amphipathic
a-helices to the hydrocarbon chains of the hydrophobic lipid core;
(4) the cell content leaks through the membrane-embedded pores
which now have a polar inner surface.
Indeed, transmembrane pores in membrane preparations of
hRBC treated with HELP at pH 5.0 are clearly visible in electron
micrographs as characteristic ring-shaped structures partially
buried within the lipid bilayer (see Figure 9), whereas in HELP-
treated membrane preparations at pH 7.5 neither lytic activity
nor pores could be detected. The electron microscopy results thus
confirmed that pore formation (integration of HELP into the lipid
bilayer) is critically governed by the pH-dependent ionization state
of the molecule. Therefore, it appears to be reasonable to assume
a direct correlation between the leakage (transmembrane passage)
of haemoglobin from hRBC and the formation of peptide/protein-
lined pores in the membrane. If the observed membrane structures
are pores with a hydrophilic interior, then packing considerations
imply that a minimal number of ~ 18—20 aggregated helices
must be involved in the formation of this circular ultrastructure
(calculated for a pore of 2.3—2.9 run inner diameter). A similar
model, involving a cluster of four molecules in which the polar
faces point inwards into the pore (ion channel), has been
suggested by Vogel and Jahnig (1986) to explain the interaction
of BVM with membranes upon which the toxin is thought to act
by traversing the lipid bilayer and Lear et al. (1988) synthesized
model ion channel peptides, which were designed to form pores
composed of bundles of aggregated membrane-spanning
amphiphilic a-helices. Alamethicin, a 20-residue peptide
antibiotic, acts by forming voltage-gated transmembrane ion
channels through aggregation in the lipid bilayer (Fox and
Richards, 1982; Bernheimer and Rudy, 1986). Furthermore, a
membranolytic Entamoeba histolytica peptide that causes pore
formation by insertion into the target-cell membranes was found
to form oligomers in solution or bound to membranes and its
N-terminal sequence revealed a structural similarity to BVM
(Leippe etai, 1991). As an, alternative transmembrane pore
forming mechanism, aggregation of integral hRBC membrane
proteins might be initiated by the amphipathic HELP molecule
binding to these proteins and perturbating their structures. The
formation of pores by aggregation of band 3, the major integral
protein of erythrocyte membranes, has been discussed by Clague
and Cherry (1988) who studied the p25 signal peptide- and BVM-
induced hRBC haemolysis and band 3 aggregation.
The work presented here is a contribution towards a more
coherent picture of the structure—function relationship of an
amphipathic peptide specifically designed to interact with lipid
bilayers in a pH-dependent fashion. Furthermore, the possibility
of constructing a peptide with a predetermined conformation and
biological activity should enable the factors which influence
peptide and protein folding to be better understood. Starting with
model building, followed by synthesis, chemical and
spectroscopical characterization of HELP and finally the
comparison between the designed and the determined structure
closes the circle and should allow the accuracy of model
construction to be improved, and to design more sophisticated
a-helices.
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